Results 61 to 70 of about 66,784,034 (314)
Since the global COVID-19 pandemic has great impact on human health and life style, the vaccination is the most effective method for disease control and prevention. However, not all people are willing to be vaccinated because some critical factors affect
Wang, Shao-Cheng +3 more
core +1 more source
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium [PDF]
We investigated effectiveness of (1) mRNA booster vaccination versus primary vaccination only and (2) heterologous (viral vector–mRNA) versus homologous (mRNA–mRNA) prime-boost vaccination against severe outcomes of BA.1, BA.2, BA.4 or BA.5 ...
A. Robert +42 more
core +1 more source
Timelines of COVID-19 Vaccines
World Health Organisation discussed the “Top Threats to Human Health in 2019,” and developed a strategic plan to meet the challenges. Among the communicable diseases. Emerging and Re-emerging viral pathogens causing Global Pandemic with devastating results were emphasised.
openaire +3 more sources
Nanomedicine and the COVID-19 vaccines [PDF]
Two nanoparticle-based vaccines close to obtaining approval by the US Food and Drug Administration could represent a giant step in the fight against the COVID-19 pandemic.
openaire +2 more sources
Stevens‐Johnson Syndrome due to COVID‐19 vaccination
As public COVID‐19 vaccination programs are being implemented, it is possible that more rare and serious adverse effects such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) may occur.
Parvin Mansouri +3 more
doaj +1 more source
Background: Overcoming coronavirus disease (COVID-19) will likely require mass vaccination. With vaccination scepticism rising in many countries, assessing the willingness to vaccinate against COVID-19 is of crucial global health importance.
Géraldine Blanchard-Rohner +3 more
doaj +1 more source
COVID‐19 vaccination, time for a second breath?
Graphical Abstract One year into the Covid‐19 vaccination campaign, C. Gerke, B. Pulverer and P. Sansonetti discuss its results and redefine its objectives.
Christiane E Gerke +2 more
doaj +1 more source
Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
In this case report, we presented a case of myocarditis as a rare complication that developed after Covid mRNA‐1273 vaccine. Cases of post‐vaccine myocarditis usually progress with mild symptoms.
Suresh Babu Chellapandian +4 more
doaj +1 more source
COVID-19 Vaccination Uptake and Related Determinants in Detained Subjects in Italy
Background: This study explored the extent of COVID-19 vaccination coverage and investigated drivers and barriers to COVID-19 vaccine uptake among people in prison.
Gabriella Di Giuseppe +5 more
doaj +1 more source
Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley +1 more source

